Fluor is providing architectural and engineering services and procuring equipment for the new 275,000 square-foot manufacturing facility that will house two manufacturing lines to double manufacturing capability
Strategic partnership aims to support significant growth of the Ibuprofen product market in Brazil and is backed by Univar Solutions' state-of-the-art Solution Center in São Paulo, Brazil
Zidavi is recommended by the Infectious Disease Society of America
Standalone Q3 FY23 revenue stood at Rs. 626.5 crore as against Rs. 594.8 crore, a growth of 5% YoY
The company will not receive any proceeds from the offer as all of it will go to the promoter selling shareholder.
Dr. Reddy’s will manufacture the Active Pharmaceutical Ingredient and finished drug at its facilities approved by USFDA
This will give either party customers access enzyme expertise and assets, resulting in cost-effective, green processing for API manufacturing.
Surana is a chartered accountant with an all-India rank.
China is now focusing on establishing volume and enhancing capabilities for innovative high value drug production
The company will submit an action plan on the observations and will engage with US FDA for next steps.
Subscribe To Our Newsletter & Stay Updated
